Vomiting can be associated with serious, severely debilitating conditions and the cause should be investigated.

Administering Cerenia on a completely empty stomach may cause the dog to vomit. A light snack before dosing could help prevent this effect.

The safety of Cerenia has not been established in dogs less than 16 weeks of age and in pregnant or lactating bitches. Use only according to a risk benefit assessment by the responsible veterinary surgeon.

Cerenia should be used in conjunction with other supportive measures if appropriate.

Clinical signs including vomiting on first administration, excess salivation and watery faeces have been observed when the product has been overdosed in excess of 20 mg/kg.

Maropitant is metabolised in the liver and therefore should be used with caution in dogs with liver disease.

Cerenia should be used with caution in animals suffering from or with a predisposition for heart diseases. Cerenia should not be used concomitantly with Ca-channel antagonists as maropitant has affinity to Ca-channels.

Maropitant is highly bound to plasma proteins and may compete with other highly bound drugs.

Cerenia is not a sedative and some motion sick dogs may show nausea-like signs during travel such as salivation and lethargy. These signs are temporary and should resolve when the journey ends.

Incidents of pre-travel vomiting can occur after dosing.

User warnings: Wash hands after use. In case of accidental ingestion seek medical advice immediately and show the package leaflet or the label to the physician.